Premier Biomedical Inc Stock OTC Bulletin Board
Equities
US74048K1043
Specialty Chemicals
End-of-day quote
Other stock markets
|
||
- USD | - |
|
Sales 2018 | 0.04 0.05 | Sales 2019 | 0.01 0.02 | Capitalization | 78.42K 107K |
---|---|---|---|---|---|
Net income 2018 | - 0 | Net income 2019 | - 0 | EV / Sales 2018 | 16,149,039 x |
Net Debt 2018 | 223K 305K | Net Debt 2019 | 89.55K 122K | EV / Sales 2019 | 11,762,132 x |
P/E ratio 2018 |
-0.74
x | P/E ratio 2019 |
-0.06
x | Employees | - |
Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 99% |
Managers | Title | Age | Since |
---|---|---|---|
Gabe Vlad
DFI | Director of Finance/CFO | - | - |
William Tynan
AUD | Comptroller/Controller/Auditor | - | - |
General Counsel | - | - |
1st Jan change | Capi. | |
---|---|---|
+18.81% | 67.25B | |
+22.90% | 43.91B | |
+36.07% | 27.95B | |
+9.18% | 19.13B | |
+15.16% | 17.16B | |
-27.02% | 15.05B | |
-14.48% | 14.38B | |
-32.66% | 11.53B | |
-32.82% | 11.45B |